サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1076355

創薬向け人工知能の世界市場 - 市場規模・シェア・動向分析：用途別（薬物の最適化と転用、前臨床試験）、治療領域別、地域別、セグメント別の予測（2022年～2030年）

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 80 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
創薬向け人工知能の世界市場 - 市場規模・シェア・動向分析：用途別（薬物の最適化と転用、前臨床試験）、治療領域別、地域別、セグメント別の予測（2022年～2030年）
出版日: 2022年04月11日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬向け人工知能の市場規模は、2030年までに91億米ドルに達し、2022年～2030年にCAGRで29.4%の成長が予測されています。

当レポートでは、世界の創薬向け人工知能市場について調査分析し、市場の動向、用途・治療領域・地域別の予測、競合分析などを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の創薬向け人工知能市場：変数・動向・範囲

  • 市場セグメンテーション
  • 創薬向け人工知能市場力学

第4章 世界の創薬向け人工知能市場：推計と動向分析、用途別

  • 創薬向け人工知能市場：用途の動向分析
  • 薬物の最適化と転用
  • 前臨床試験
  • その他の用途

第5章 世界の創薬向け人工知能市場：推計と動向分析、治療領域別

  • 創薬向け人工知能：治療領域の動向分析
  • 腫瘍
  • 神経変性疾患
  • 循環器疾患
  • 代謝性疾患
  • 感染症
  • その他

第6章 世界の創薬向け人工知能市場：推計と動向分析、地域別

  • 世界の創薬向け人工知能市場の動向分析：地域別
  • 世界の創薬向け人工知能市場のシェア：地域別（2021年・2030年）
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • ロシア
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • シンガポール
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第7章 競合分析

  • 最近の動向と影響分析：主要な市場参入企業別
  • 企業/競合の分類（主要なイノベーター、マーケットリーダー、新興企業）
  • 競合ダッシュボード・企業市況分析
    • シナジー分析：主要な取引と戦略的提携
    • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト

第8章 競合情勢

  • IBM Watson
  • Exscientia
  • GNS Healthcare
  • Alphabet(DeepMind)
  • Benevolent AI
  • BioSymetrics
  • Euretos.
  • Berg Health
  • Atomwise
  • Insitro
  • Cyclica
図表

List of Tables

  • Table 1 Partial list of secondary sources
  • Table 2 North America Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 6 Canada Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 8 Europe Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 9 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 10 U.K. Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 11 U.K. Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 12 Germany Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 13 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 14 France Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 15 France Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 16 Spain Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 17 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 18 Italy Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 19 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 20 Russia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 21 Russia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 22 Asia Pacific Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 23 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 24 China Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 25 China Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 26 India Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 27 India Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 28 Japan Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 29 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 30 Australia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 31 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 32 Singapore Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 33 Singapore Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 34 South Korea Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 35 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 36 Latin America Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 37 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 38 Brazil Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 39 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 40 Mexico Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 41 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 42 Argentina Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 43 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 44 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 45 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 46 South Africa Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 47 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 48 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 49 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 50 UAE Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 51 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
  • Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
  • Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
  • Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
  • Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
  • Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
  • Fig. 14 Global Artificial Intelligence in drug discovery market - Porter's Analysis
  • Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
  • Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
  • Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 18 Preclinical testing market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
  • Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
  • Fig. 22 Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 24 Cardiovascular Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 25 Metabolic Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
  • Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
  • Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 33 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 34 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 35 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 36 France Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 37 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 38 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 39 Russia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 41 China Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 42 India Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 43 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 44 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 45 Singapore Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 46 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 47 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 48 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 49 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 50 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 51 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 52 South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 54 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 55 Recent Developments & Impact Analysis, By Key Market Participants
  • Fig. 56 Company market position analysis, 2021
  • Fig. 57 Strategic alliance and deals analysis
目次
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends:

The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 29.4% from 2022 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2021. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2021. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2021. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights:

  • The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 50.0% in 2021
  • By therapeutic area, the oncology segment held the largest revenue share of over 20.0% in 2021. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
  • Asia Pacific is expected to expand at the fastest CAGR of 32.2% from 2022 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
  • North America led the market and accounted for a revenue share of over 55.0% in 2021. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Segment Share Calculation
  • 1.5 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Artificial Intelligence in Drug Discovery Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
    • 3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter's Analysis

Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
  • 4.2 Drug Optimisation and Repurposing
    • 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 4.3 Preclinical Testing
    • 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 4.4 Other Applications
    • 4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.3 Neurodegenerative Diseases
    • 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.4 Cardiovascular Disease
    • 5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.5 Metabolic Diseases
    • 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.6 Infectious Disease
    • 5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region
  • 6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030
  • 6.3 North America
    • 6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.2 U.K.
      • 6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.5 Spain
      • 6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.6 Italy
      • 6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.7 Russia
      • 6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.2 China
      • 6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.3 India
      • 6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.4 Japan
      • 6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.6 Singapore
      • 6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.7 South Korea
      • 6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.3 Mexico
      • 6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.7 MEA
    • 6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 7.3. Competitive Dashboard & Company Market Position Analysis
    • 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
    • 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators

Chapter 8 Competitive Landscape

  • 8.1 IBM Watson
    • 8.1.1 Company Overview
    • 8.1.2 Finanacial Performance
    • 8.1.3 Offerings
    • 8.1.4 Strategic Initiatives
  • 8.2 Exscientia
    • 8.2.1 Company Overview
    • 8.2.2 Finanacial Performance
    • 8.2.3 Offerings
    • 8.2.4 Strategic Initiatives
  • 8.3 GNS Healthcare
    • 8.3.1 Company Overview
    • 8.3.2 Finanacial Performance
    • 8.3.3 Offerings
    • 8.3.4 Strategic Initiatives
  • 8.4 Alphabet (DeepMind)
    • 8.4.1 Company Overview
    • 8.4.2 Finanacial Performance
    • 8.4.3 Offerings
    • 8.4.4 Strategic Initiatives
  • 8.5 Benevolent AI
    • 8.5.1 Company Overview
    • 8.5.2 Finanacial Performance
    • 8.5.3 Offerings
    • 8.5.4 Strategic Initiatives
  • 8.6 BioSymetrics
    • 8.6.1 Company Overview
    • 8.6.2 Finanacial Performance
    • 8.6.3 Offerings
    • 8.6.4 Strategic Initiatives
  • 8.7 Euretos.
    • 8.7.1 Company Overview
    • 8.7.2 Finanacial Performance
    • 8.7.3 Offerings
    • 8.7.4 Strategic Initiatives
  • 8.8 Berg Health
    • 8.8.1 Company Overview
    • 8.8.2 Finanacial Performance
    • 8.8.3 Offerings
    • 8.8.4 Strategic Initiatives
  • 8.9 Atomwise
    • 8.9.1 Company Overview
    • 8.9.2 Finanacial Performance
    • 8.9.3 Offerings
    • 8.9.4 Strategic Initiatives
  • 8.10 Insitro
    • 8.10.1 Company Overview
    • 8.10.2 Finanacial Performance
    • 8.10.3 Offerings
    • 8.10.4 Strategic Initiatives
  • 8.11 Cyclica
    • 8.11.1 Company Overview
    • 8.11.2 Finanacial Performance
    • 8.11.3 Offerings
    • 8.11.4 Strategic Initiatives